What did ResMed pay for MediFox Dan?

ResMed acquired MediFox Dan for $990.1M in 2022 (28.3x EBITDA), equivalent to 11.90x revenue. Target revenue was approximately $83.0M. Target EBITDA was approximately $35.0M.

What does MediFox Dan do?

MediFox Dan is a healthcare it business.

What multiple did ResMed pay for MediFox Dan?

28.3x EBITDA and 11.90x revenue, based on disclosed deal value of $990.1M and disclosed financials.

M&A TRANSACTION · 2022

MediFox Dan acquired by ResMed

$990.1M· 28.3x EBITDA· 11.90x revenue

Target

MediFox Dan

Acquirer

ResMed

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$83.0M

EBITDA

$35.0M

Deal Value

$990.1M

EV/EBITDA

28.3x

Context

This $990.1M acquisition of MediFox Dan by ResMed sits in the healthcare it sub-vertical. The 28.3x EBITDA multiple paid in 2022 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. ResMed is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from SEC filings and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the MediFox Dan acquisition.

Citation: ExitValue.ai. (2022). MediFox Dan acquired by ResMed. https://exitvalue.ai/deals/medifox-dan-acquired-by-resmed-hc-2022-0066